| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | — |
| Cost of Revenue | $682K | -38.0% |
| Gross Profit | $1.7M | -28.3% |
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $5.9M | +11.9% |
| Operating Income | -$22.8M | — |
| Interest Expense | $7K | -19.8% |
| Net Income | -$23.1M | -3936.3% |
| EPS (Basic) | -$0.02 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58K | -53.4% |
| Accounts Receivable | $15K | -54.0% |
| Inventory | $111K | -74.8% |
| Current Assets | $308K | — |
| Total Assets | $509K | +1507.3% |
| Current Liabilities | $3.6M | +1332.6% |
| Long-term Debt | $1.1M | +468.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$324K | -2328.6% |
| Capital Expenditures | $189K | — |
| Investing Cash Flow | -$188K | — |
| Financing Cash Flow | $442K | +3389.2% |
| Free Cash Flow | -$514K | -3747.6% |
| — |
| EPS (Diluted) | -$0.02 | — |
| Total Liabilities |
| $3.9M |
| +1433.0% |
| Stockholders' Equity | -$3.4M | -1422.4% |